相关实验视频

Updated: May 7, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

HER2异常是肺外小细胞神经内分泌癌的潜在预测生物标志物,与小细胞肺癌相反

Nikola Hájková¹, Klára Pavlíčková², Jiří Dvořák¹

¹Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.

Virchows Archiv : an international journal of pathology

|October 14, 2025

概括

在小细胞肺癌 (SCLC) 和肺外小细胞神经内分泌癌 (EP-SCNC) 中分析了人类表皮生长因子受体2 (HER2) 突变和放大. 在EP-SCNC中,HER2异常更频繁,这表明它有可能成为治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

小细胞肺癌 (SCLC) 和肺外小细胞神经内分泌癌 (EP-SCNC) 是罕见的神经内分泌瘤.
人类表皮生长因子受体2 (HER2) 在这些癌症中的作用尚不清楚.

研究的目的:

调查HER2异常的频率和重要性 (基因放大,突变,蛋白质表达) 在SCLC和EP-SCNC.
探索HER2作为EP-SCNC的治疗点的潜力.

主要方法:

使用RNA测序等技术分析HER2基因放大,突变和mRNA表达.
免疫组织化学 (IHC) 用于评估HER2蛋白表达.
患者队列包括123个SCLC和128个EP-SCNC样本.

主要成果:

在5.5%的EP-SCNC (尿膀,结肠,门,子宫) 和0.8%的SCLC中发现了HER2突变.
在2.3%的EP-SCNC中发现了HER2基因放大,但在SCLC中没有发现.
在一些EP-SCNC和SCLC中观察到高HER2mRNA表达,在大多数情况下相应的HER2蛋白质阳性.

结论:

在EP-SCNCs中,HER2异常,特别是突变,比在SCLC中更为普遍.
作为EP-SCNC的潜在治疗点,HER2值得进一步研究.
在EP-SCNC中HER2过度表达的预后价值需要进一步研究.

关键词:

在HER2 mRNA中.这是一种HER2突变.反-HER2的反-HER2的使用方法肺外小细胞神经内分泌癌 HER2 蛋白质是HER2 蛋白质的一种蛋白质.小细胞肺癌的癌症.

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...